Sema4 to Participate at Two Upcoming Investor Conferences in February

Rhea-AI Summary

Sema4 (Nasdaq: SMFR) announced its participation in upcoming virtual investor conferences. The company will hold a fireside chat and one-on-one meetings at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17, 2022, at 10:00 a.m. ET. Furthermore, Sema4 will present at the SVB Leerink 11th Annual Global Healthcare Conference on February 18, 2022, at 2:20 p.m. ET, with a subsequent live and archived webcast available on its investor relations website.

Sema4 is focused on transforming healthcare through AI-driven genomic and clinical data insights.

STAMFORD, Conn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate at the following virtual investor conferences:

• BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
  Fireside chat and 1x1s on Thursday, February 17^th, 2022 at 10:00 a.m. ET
  

• SVB Leerink 11^th Annual Global Healthcare Conference
  Formal presentation and 1x1s on Friday, February 18^th, 2022 at 2:20 p.m. ET
  

A live and archived webcast of the SVB Leerink presentation will be available on the “Events” section of the Sema4 investor relations website at https://ir.sema4.com/.

About Sema4

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis®, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

Investor Relations Contact:
Joel Kaufman
Sema4
investors@sema4.com

Media Contact:
Radley Moss
Sema4
radley.moss@sema4.com

FAQ

What events is Sema4 participating in February 2022?

Sema4 is participating in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17, 2022, and the SVB Leerink 11th Annual Global Healthcare Conference on February 18, 2022.

When will Sema4's presentation be available online?

A live and archived webcast of Sema4's presentation at the SVB Leerink conference will be available on their investor relations website.

What time is Sema4's fireside chat at the BTIG Conference?

Sema4's fireside chat at the BTIG Conference is scheduled for February 17, 2022, at 10:00 a.m. ET.

What time is Sema4 scheduled to present at the SVB Leerink Conference?

Sema4 is scheduled to present at the SVB Leerink Conference on February 18, 2022, at 2:20 p.m. ET.

What is the stock symbol for Sema4?

Sema4 trades under the stock symbol SMFR and SMFRW.